StonvexLoading…
StonvexStonvexStonvexCore line items from ITRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.37B | $2.44B | $2.17B | $1.80B |
Operating Income | $313.07M | $264.11M | $128.87M | $-7.44M |
Net Income | $301.06M | $239.10M | $96.92M | $-9.73M |
EPS (Diluted) | $6.50 | $5.18 | $2.11 | $-0.22 |
Total Assets | $3.72B | $3.41B | $2.60B | $2.38B |
Total Liabilities | $1.98B | $2.00B | $1.27B | $1.19B |
Cash & Equivalents | $1.02B | $1.05B | $302.05M | $202.01M |
Free Cash Flow OCF − CapEx | $383.06M | $207.61M | $98.09M | $4.75M |
Shares Outstanding | 44.93M | 45.13M | 45.51M | 45.19M |